相似文献
1
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.癌症患者体内分离出的细菌对左氧氟沙星及其他喹诺酮类药物的敏感性。
Antimicrob Agents Chemother. 1994 Apr;38(4):848-52. doi: 10.1128/AAC.38.4.848.
2
In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.曲伐沙星对癌症患者临床分离细菌的体外活性
J Antimicrob Chemother. 1997 Jun;39 Suppl B:15-22. doi: 10.1093/jac/39.suppl_2.15.
3
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.司帕沙星与环丙沙星及氧氟沙星相比对呼吸道病原体的体外活性。
Chemotherapy. 1993;39(1):32-5. doi: 10.1159/000238970.
4
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].左氧氟沙星及其他抗生素对新鲜临床分离株的体外活性
Jpn J Antibiot. 1999 Sep;52(9):571-84.
5
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.环丙沙星、左氧氟沙星、洛美沙星、氧氟沙星、培氟沙星、司帕沙星和曲伐沙星对呼吸道感染革兰氏阳性和革兰氏阴性病原体的体外活性。
J Antimicrob Chemother. 1997 Sep;40(3):427-31. doi: 10.1093/jac/40.3.427.
6
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].[加替沙星对2002年各种新鲜临床分离株的抗菌活性]
Jpn J Antibiot. 2002 Dec;55(6):800-7.
7
Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.通过E试验比较三种氟喹诺酮类药物对临床分离株的体外活性。
Chemotherapy. 2003 Jul;49(4):184-8. doi: 10.1159/000071142.
8
In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.司帕沙星、环丙沙星、氧氟沙星及其他抗生素对革兰氏阳性球菌血流感染分离株的体外活性
Diagn Microbiol Infect Dis. 1993 Jul;17(1):85-91. doi: 10.1016/0732-8893(93)90077-k.
9
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.新型喹诺酮类药物PD 117558对癌症患者分离出的细菌菌株的体外活性
J Antimicrob Chemother. 1989 Mar;23(3):363-71. doi: 10.1093/jac/23.3.363.
10
In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.强效喹诺酮类药物DQ - 113对临床分离株的体外抗菌活性。
Antimicrob Agents Chemother. 2002 Mar;46(3):904-8. doi: 10.1128/AAC.46.3.904-908.2002.
引用本文的文献
1
Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli.
Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):405-10. doi: 10.1007/s10096-005-1344-4.
2
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.环丙沙星、左氧氟沙星或莫西沙星治疗实验性金黄色葡萄球菌角膜炎的有效性。
Antimicrob Agents Chemother. 2004 Jun;48(6):1948-52. doi: 10.1128/AAC.48.6.1948-1952.2004.
3
Ofloxacin otic solution: a review of its use in the management of ear infections.氧氟沙星耳用溶液：用于耳部感染治疗的综述
Drugs. 1999 Sep;58(3):509-31. doi: 10.2165/00003495-199958030-00019.
4
Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.左氧氟沙星。其在呼吸道、皮肤、软组织及泌尿系统感染中的应用。
Drugs. 1998 Sep;56(3):487-515. doi: 10.2165/00003495-199856030-00013.
5
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.左氧氟沙星与环丙沙星、氟氯西林或万古霉素治疗甲氧西林敏感或耐药金黄色葡萄球菌所致实验性心内膜炎的疗效比较
Antimicrob Agents Chemother. 1997 Aug;41(8):1662-7. doi: 10.1128/AAC.41.8.1662.
6
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.曲伐沙星单独及与其他药物联合应用对革兰阴性非发酵菌的比较活性
Antimicrob Agents Chemother. 1997 Jul;41(7):1475-81. doi: 10.1128/AAC.41.7.1475.
7
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.通过棋盘法和时间杀菌研究测定左氧氟沙星、氧氟沙星和环丙沙星单独及与阿米卡星联合使用时对不动杆菌的活性。
Antimicrob Agents Chemother. 1997 May;41(5):1073-6. doi: 10.1128/AAC.41.5.1073.
8
In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.左氧氟沙星和环丙沙星在由甲氧西林敏感和耐药金黄色葡萄球菌菌株诱导的急性小鼠血源性肾盂肾炎中的体内疗效。
Antimicrob Agents Chemother. 1996 Nov;40(11):2529-34. doi: 10.1128/AAC.40.11.2529.
9
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.百日咳博德特氏菌和副百日咳博德特氏菌对四种氟喹诺酮类药物（左氧氟沙星、d-氧氟沙星、氧氟沙星和环丙沙星）、头孢匹罗和美罗培南的体外敏感性。
Antimicrob Agents Chemother. 1996 Mar;40(3):807-8. doi: 10.1128/AAC.40.3.807.
10
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.非铜绿假单胞菌革兰氏阴性非发酵菌对环丙沙星、氧氟沙星、左氧氟沙星、D-氧氟沙星、司帕沙星、头孢他啶、哌拉西林、哌拉西林-他唑巴坦、甲氧苄啶-磺胺甲恶唑和亚胺培南的敏感性。
Antimicrob Agents Chemother. 1996 Mar;40(3):772-5. doi: 10.1128/AAC.40.3.772.
本文引用的文献
1
Ciprofloxacin-induced nephrotoxicity in patients with cancer.
Arch Intern Med. 1993 May 24;153(10):1258-62.
2
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.癌症低风险中性粒细胞减少患者发热发作的门诊治疗。
Cancer. 1993 Jun 1;71(11):3640-6. doi: 10.1002/1097-0142(19930601)71:11<3640::aid-cncr2820711128>3.0.co;2-h.
3
Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method.采用时间杀菌法测定左氧氟沙星（L-氧氟沙星）与苯唑西林对耐喹诺酮金黄色葡萄球菌的协同作用。
Antimicrob Agents Chemother. 1993 Feb;37(2):339-41. doi: 10.1128/AAC.37.2.339.
4
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.口服诺氟沙星预防急性白血病和粒细胞减少症患者革兰氏阴性菌感染。一项随机、双盲、安慰剂对照试验。
Ann Intern Med. 1987 Jan;106(1):1-7. doi: 10.7326/0003-4819-106-1-1.
5
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.急性白血病的感染预防：环丙沙星与复方新诺明及黏菌素的比较
Ann Intern Med. 1987 Jan;106(1):7-11. doi: 10.7326/0003-4819-106-1-7.
6
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
J Antimicrob Chemother. 1988 May;21(5):647-55. doi: 10.1093/jac/21.5.647.
7
In vitro activity of DR-3355, an optically active ofloxacin.光学活性氧氟沙星DR-3355的体外活性
Antimicrob Agents Chemother. 1988 Sep;32(9):1336-40. doi: 10.1128/AAC.32.9.1336.
8
Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Am J Med. 1987 Jun 26;82(6B):40-6. doi: 10.1016/0002-9343(87)90617-6.
9
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.氟喹诺酮类药物：结构、作用机制与耐药性以及体外活性谱
Antimicrob Agents Chemother. 1985 Oct;28(4):581-6. doi: 10.1128/AAC.28.4.581.
10
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.环丙沙星联合阿洛西林与头孢他啶联合阿米卡星用于发热性中性粒细胞减少患者经验性治疗的多中心随机试验
Am J Med. 1989 Nov 30;87(5A):278S-282S. doi: 10.1016/0002-9343(89)90080-6.
Zotero 插件